Dow Jones

44,860.31

0.28%

Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

Regístrate

VINC

Vincerx (VINC)

Vincerx Inc

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:VINC

1 2 Próxima >

Fecha	Hora	Fuente	Título	Símbolo	Compañía
25/11/2024	16:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VINC	Vincerx Inc
12/11/2024	08:00	GlobeNewswire Inc.	Vincerx Pharma Reports Third Quarter 2024 Financial Results	NASDAQ:VINC	Vincerx Inc
05/11/2024	08:15	Edgar (US Regulatory)	Form PRE 14A - Other preliminary proxy statements	NASDAQ:VINC	Vincerx Inc
07/10/2024	15:05	GlobeNewswire Inc.	Vincerx Reports Positive Initial Clinical Data from Ongoing VIP943 Phase 1 Dose-Escalation Study and Provides Pipeline and Corporate Updates	NASDAQ:VINC	Vincerx Inc
30/09/2024	05:57	Edgar (US Regulatory)	Form SC TO-I/A - Tender offer statement by Issuer: [Amend]	NASDAQ:VINC	Vincerx Inc
14/08/2024	19:03	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VINC	Vincerx Inc
13/08/2024	15:06	Edgar (US Regulatory)	Form SC TO-I - Tender offer statement by Issuer	NASDAQ:VINC	Vincerx Inc
08/08/2024	15:39	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:VINC	Vincerx Inc
08/08/2024	15:30	GlobeNewswire Inc.	Vincerx Pharma Reports Second Quarter 2024 Financial Results	NASDAQ:VINC	Vincerx Inc
02/08/2024	15:01	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:VINC	Vincerx Inc
08/07/2024	15:45	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:VINC	Vincerx Inc
14/05/2024	15:15	GlobeNewswire Inc.	Vincerx Pharma Reports First Quarter 2024 Financial Results and Provides Corporate Update	NASDAQ:VINC	Vincerx Inc
25/04/2024	23:27	GlobeNewswire Inc.	Vincerx Pharma Announces Pricing of Underwritten Public Offering of Common Stock and Warrants	NASDAQ:VINC	Vincerx Inc
25/04/2024	15:01	GlobeNewswire Inc.	Vincerx Pharma Announces Proposed Underwritten Public Offering of Common Stock and Warrants	NASDAQ:VINC	Vincerx Inc
08/04/2024	15:30	GlobeNewswire Inc.	Vincerx Pharma Presents Positive Preliminary Phase 1 Data for VIP236 and Updates on Pipeline Progress at the American Association for Cancer Research (AACR) Annual Meeting 2024	NASDAQ:VINC	Vincerx Inc
01/04/2024	07:00	GlobeNewswire Inc.	Vincerx to Host Virtual Investor Event Reviewing Preliminary Phase 1 VIP236 Data Presented at the American Association for Cancer Research (AACR) Annual Meeting 2024	NASDAQ:VINC	Vincerx Inc
29/03/2024	14:20	GlobeNewswire Inc.	Vincerx Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Update	NASDAQ:VINC	Vincerx Inc
05/03/2024	15:31	GlobeNewswire Inc.	Vincerx to Present Three Posters at the American Association for Cancer Research (AACR) Annual Meeting 2024	NASDAQ:VINC	Vincerx Inc
13/10/2023	08:12	GlobeNewswire Inc.	New to The Street Airs Televised Corporate Interviews Episodes 521 and 522 as Sponsored Programming on Bloomberg TV and The Fox Business Network	NASDAQ:VINC	Vincerx Inc
06/10/2023	08:30	GlobeNewswire Inc.	New to The Street Announces TV Corporate Appearances, broadcasting Episode 518 on Newsmax and Episode 519 on FOX Business Network, Airings start on Saturday, October 7, 2023, at 3:30 PM ET	NASDAQ:VINC	Vincerx Inc
20/06/2023	15:07	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:VINC	Vincerx Inc
11/05/2023	15:02	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:VINC	Vincerx Inc
12/04/2023	15:14	Edgar (US Regulatory)	Annual Report to Security Holders (ars)	NASDAQ:VINC	Vincerx Inc
28/03/2023	16:07	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	NASDAQ:VINC	Vincerx Inc
28/03/2023	15:50	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:VINC	Vincerx Inc
16/02/2023	15:08	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:VINC	Vincerx Inc
10/02/2023	15:02	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:VINC	Vincerx Inc
13/11/2022	21:55	TipRanks	SVB Securities Sticks to Its Buy Rating for Vincerx Pharma Inc (VINC)	NASDAQ:VINC	Vincerx Inc
06/11/2022	21:35	TipRanks	SVB Securities Remains a Buy on Vincerx Pharma Inc (VINC)	NASDAQ:VINC	Vincerx Inc
12/08/2022	07:36	TipRanks	Vincerx Pharma Inc (VINC) Receives a Buy from SVB Securities	NASDAQ:VINC	Vincerx Inc